- Business Wire•3 days ago
Puma Biotechnology, Inc. , a biopharmaceutical company, announced the closing of an underwritten public offering of 4,312,500 shares of its common stock at a price to the public of $40.00 per share.
- 24/7 Wall St.•5 days ago
Some companies are hitting lows and creating huge shareholder losses while the market is just below all-time highs but still struggling. These are the same companies holding back the market and punishing ...
- Benzinga•7 days agoPuma Biotech, Which Had Weak Demand For A Secondary Offering, Is Also Part Of The SEC Tick Size Pilot Program
Puma Biotechnology Inc (NYSE: PBYI ) has had one of its most volatile weeks in recent memory thanks to weak demand for a secondary offering. falling over 28 percent from its Tuesday high of $54.65 To ...
Puma Biotechnology, Inc. (PBYI)
NYSE - NYSE Delayed Price. Currency in USD
|Bid||39.25 x 100|
|Ask||40.00 x 1200|
|Day's Range||38.10 - 40.70|
|52wk Range||19.74 - 94.93|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.90|
|Avg Vol (3m)||1,031,884|
|Dividend & Yield||N/A (N/A)|